Increased serum thyroglobulin levels and negative imaging in thyroid cancer patients: are there sources of benign secretion? A speculative short review

• Published in: Nuclear medicine communications Vol. 31; no. 12; p. 1054
• Main Authors: Zanotti-Fregonara, Paolo, Keller, Isabelle, Calzada-Nocaudie, Marie, Al-Nahhas, Adil, Devaux, Jean-Yves, Grassetto, Gaia, Marzola, Maria Cristina, Rubello, Domenico, Hindié, Elif
• Format: Journal Article
• Language: English
• Published: England 01.12.2010
• Subjects: Diagnostic Imaging; Humans; Thymus Gland - drug effects; Thymus Gland - secretion; Thyroglobulin - blood; Thyroglobulin - secretion; Thyroid Dysgenesis - metabolism; Thyroid Neoplasms - blood; Thyroid Neoplasms - diagnosis; Thyroid Neoplasms - secretion; Thyroid Neoplasms - surgery; Thyrotropin - pharmacology
• ISSN: 1473-5628
• DOI: 10.1097/MNM.0b013e328340e717

After thyroidectomy and 131I ablation for differentiated thyroid cancer (DTC), serum thyroglobulin (Tg) became a sensitive marker of residual disease. It is not uncommon to find patients at follow-up with persistent serum Tg levels and no other clinical or imaging evidence for the disease. The vast majority of these patients, most probably, have occult foci of disease, often in minute cervical lymph nodes. A review of the literature including papers published on PubMed/Medline until June 2010 was made. In this study we speculated that a minority of patients who had undergone surgery for differentiated thyroid cancer might have benign sources of Tg secretion at follow-up. These sources may be foci of radio-resistant ectopic thyroid tissue or a thyroid stimulating hormone-stimulated thymus.